https://scholars.lib.ntu.edu.tw/handle/123456789/187642
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 內科 | en |
dc.contributor.author | HUANG, GUAN-TARN | en |
dc.contributor.author | LEE, PO-HUANG | en |
dc.contributor.author | TSANG, YUK-MING | en |
dc.contributor.author | LAI, MING-YANG | en |
dc.contributor.author | YANG, PEI-MING | en |
dc.contributor.author | HU, REY-HENG | en |
dc.contributor.author | CHEN, PEI-JER | en |
dc.contributor.author | KAO, JIA-HORNG | en |
dc.contributor.author | SHEU, JIN-CHUAN | en |
dc.contributor.author | LEE, CHA-ZE | en |
dc.contributor.author | CHEN, DING-SHINN | en |
dc.contributor.author | 李伯皇 | zh_TW |
dc.contributor.author | 陳培哲 | zh_TW |
dc.creator | 黃冠棠;李伯皇;曾旭明;賴明陽;楊培銘;胡瑞恆;陳培哲;高嘉宏;許金川;李嘉哲;陳定信 | zh_TW |
dc.creator | HUANG, GUAN-TARN;LEE, PO-HUANG;TSANG, YUK-MING;LAI, MING-YANG;YANG, PEI-MING;HU, REY-HENG;CHEN, PEI-JER;KAO, JIA-HORNG;SHEU, JIN-CHUAN;LEE, CHA-ZE;CHEN, DING-SHINN | en |
dc.date | 2005 | en |
dc.date.accessioned | 2008-12-05T02:17:38Z | - |
dc.date.accessioned | 2018-07-11T05:02:40Z | - |
dc.date.available | 2008-12-05T02:17:38Z | - |
dc.date.available | 2018-07-11T05:02:40Z | - |
dc.date.issued | 2005 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/88389 | - |
dc.description.abstract | Objective: To compare disease recurrence and survival among patients with small hepatocellular carcinoma after surgical resection or percutaneous ethanol injection therapy, 2 treatments that have not been evaluated with a prospective study. Methods: A total of 76 patients were randomly assigned to 2 groups based on treatment; all had one or 2 tumors with diameter <=3 cm, with hepatitis without cirrhosis or Child class A or B cirrhosis without evident ascites or bleeding tendency. Results: Follow-up ranged from 12 to 59 months. Among percutaneous injection patients, 18 had recurrence 1 to 37 months after treatment (true recurrence, 11; original safety margin inadequate, 3; limitation of imaging technology to detect tiny tumors, 4). Three injection therapy patients died of cancer 25 , 37, and 57 months after treatment. For the surgical resection group, 15 had recurrence 2 to 54 months after treatment (true recurrence, 12; limitation of imaging, 2; neck metastasis, 1 ). Five resection patients died of cancer at 11, 20, 23, 26, and 52 months, respectively. By Cox regression model and Kaplan-Meier survival analysis, there is no statistical significance for recurrence and survival between treatment groups. However, tumor size larger than 2 cm and alpha- fetoprotein over 200 ng/mL correlated with higher recurrence rate, and Child class B liver cirrhosis correlated with shorter survival. Conclusions: Percutaneous ethanol injection therapy appears to be as safe and effective as resection , and both treatments can be considered first-line options for small hepatocellular carcinoma. | en |
dc.language | en-us | en |
dc.language.iso | en_US | - |
dc.relation | ANNALS OF SURGERY v.242 n.1 pp.36-42 | en |
dc.relation.ispartof | ANNALS OF SURGERY | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study | en |
dc.relation.pages | 36-42 | - |
dc.relation.journalvolume | v.242 | - |
dc.relation.journalissue | n.1 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en_US | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。